Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Cutting-edge technology in predicting cardiovascular problems now in UAE

Article-Cutting-edge technology in predicting cardiovascular problems now in UAE

The technology processes all vital ECG parameters to create an alerting feature that notifies on increased stroke or heart attack risks.

Diginova Health Solutions, a digital healthcare start-up based at the DIFC, recently announced its partnership with Finnish firm Cardiolyse, to bring its award-winning cloud ECG & HRV analytics platform in the UAE. Cardiolyse is an ECG & HRV predictive analytics platform for real-time remote heart health and fatigue risks monitoring, providing plain personalised reports, detection and up to two months data-based prognosis on dangerous heart events.

“An estimated 80 per cent of cardiovascular disease (CVD), including heart disease and stroke, are preventable, but sadly it remains one of the leading causes of death in the UAE and around the world. CVD complications are accountable for more than 50 per cent of all deaths among people with diabetes, which unfortunately is a grim reality in the UAE, with over a million people living with it,” says Dr. Sarper Tanli, Co-Founder and CEO of Diginova Health Solutions.

Cardiolyse's proprietary patent-pending machine-learning algorithms process all vital ECG parameters to create an alerting feature that notifies both patient and his doctor on increased stroke or heart attack risks, enabling the prevention of critical heart events up to two months before they occur. As a device-agnostic cloud platform, Cardiolyse cuts off the need for complicated time-consuming integration by pairing its solution with any type of digital ECG device via universal API (application programming interface).

The ecosystem is comprised of customised web dashboards for both patients and physicians, as well as independent Android and iOS applications for each user type needs. "Global healthcare is in obvious and desperate need for disruptive technologies, and we are grateful for the opportunity to partner with Diginova in bringing Cardiolyse to the UAE to support the region’s digital transformation as it serves the emerging challenges of both healthcare providers and personal health-conscious patients," commented Anna Starynska, Co-Founder and CEO at Cardiolyse. "Our primary goal here is to provide timely and data-driven insights for physicians and cardiologists to support the cost-effective patient-centric diagnosticating approach and more accurate self-care solutions for patients.

Dr. Sarper adds, “The MENA digital healthcare space is severely underserved, with per capita spending lagging behind EU and the U.S. by as much as 60 per cent. Our job at Diginova is to identify gaps in the market and facilitate digital health products and solutions through entrepreneurs and accelerator programmes. Through our partnership with Cardiolyse we are committed to amplify the impact and scale of digital heath solutions in the region. Diginova also confirmed that the UAE launch of Cardiolyse will be followed by a region-wide entry across the GCC, starting immediately with KSA.”

TAGS: Cardiology
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.